Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Controlled Ovarian Stimulation With Corifollitropin Alpha in Patients With Expected or Poor Ovarian Response in IVF Cycles
NCT02118051Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Sep 2013
- Primary completion
- Jun 2017
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised trial of corifollitropin alfa in infertility (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoints: Rate of evolutionary gestation in each cycle at 20 weeks and Oocytes (MII) rate by patient. Started Sep 2013; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02118051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118051.